125 related articles for article (PubMed ID: 38326133)
41. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice.
McBride D; Brüggenjürgen B; Roll S; Willich SN
J Thromb Thrombolysis; 2007 Aug; 24(1):65-72. PubMed ID: 17260164
[TBL] [Abstract][Full Text] [Related]
42. First Diagnosis of Atrial Fibrillation at the Time of Stroke.
Borowsky LH; Regan S; Chang Y; Ayres A; Greenberg SM; Singer DE
Cerebrovasc Dis; 2017; 43(3-4):192-199. PubMed ID: 28208140
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.
Sudlow M; Thomson R; Thwaites B; Rodgers H; Kenny RA
Lancet; 1998 Oct; 352(9135):1167-71. PubMed ID: 9777832
[TBL] [Abstract][Full Text] [Related]
44. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
[TBL] [Abstract][Full Text] [Related]
45. Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis.
Walkey AJ; Quinn EK; Winter MR; McManus DD; Benjamin EJ
JAMA Cardiol; 2016 Sep; 1(6):682-90. PubMed ID: 27487456
[TBL] [Abstract][Full Text] [Related]
46. Results, barriers and enablers in atrial fibrillation case finding: barriers in opportunistic atrial fibrillation case finding-a cross-sectional study.
Ballesta-Ors J; Clua-Espuny JL; Gentille-Lorente DI; Lechuga-Duran I; Fernández-Saez J; Muria-Subirats E; Blasco-Mulet M; Lorman-Carbo B; Alegret JM
Fam Pract; 2020 Sep; 37(4):486-492. PubMed ID: 32219320
[TBL] [Abstract][Full Text] [Related]
47. A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.
Engdahl J; Holmén A; Rosenqvist M; Strömberg U
Europace; 2018 Nov; 20(FI_3):f306-f311. PubMed ID: 29688312
[TBL] [Abstract][Full Text] [Related]
48. Evaluation and management of atrial fibrillation.
Ali S; Hong M; Antezano ES; Mangat I
Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):233-44. PubMed ID: 17378769
[TBL] [Abstract][Full Text] [Related]
49. Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study.
Ono F; Akiyama S; Suzuki A; Ikeda Y; Takahashi A; Matsuoka H; Sasaki M; Okamura T; Yoshihara N;
BMC Cardiovasc Disord; 2019 Oct; 19(1):235. PubMed ID: 31651245
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology and Outcomes of Abdominal Aortic Aneurysms in New Zealand: A 15-Year Experience at a Regional Hospital.
Chiang N; Jain JK; Hulme KR; Vasudevan T
Ann Vasc Surg; 2018 Jan; 46():274-284. PubMed ID: 28739467
[TBL] [Abstract][Full Text] [Related]
51. Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial.
Gladstone DJ; Wachter R; Schmalstieg-Bahr K; Quinn FR; Hummers E; Ivers N; Marsden T; Thornton A; Djuric A; Suerbaum J; von Grünhagen D; McIntyre WF; Benz AP; Wong JA; Merali F; Henein S; Nichol C; Connolly SJ; Healey JS;
JAMA Cardiol; 2021 May; 6(5):558-567. PubMed ID: 33625468
[TBL] [Abstract][Full Text] [Related]
52. Guidelines for stroke prevention in patients with atrial fibrillation.
Howard PA
Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
[TBL] [Abstract][Full Text] [Related]
53. Systematic screening for the detection of atrial fibrillation.
Moran PS; Teljeur C; Ryan M; Smith SM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009586. PubMed ID: 27258214
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors.
Abdel-Qadir H; Singh SM; Pang A; Austin PC; Jackevicius CA; Tu K; Dorian P; Ko DT
JAMA Cardiol; 2021 Aug; 6(8):918-925. PubMed ID: 34009232
[TBL] [Abstract][Full Text] [Related]
55. Pre-stroke anticoagulation for atrial fibrillation in primary English speakers and non-primary English speakers: a multicentre retrospective cohort study.
Bacchi S; Kovoor JG; Goh R; Gupta AK; Tan S; Ovenden CD; To MS; Moey A; Sanders P; Chew DP; Schultz D; Kovoor P; Kleinig T; Jannes J
Intern Med J; 2024 Apr; 54(4):620-625. PubMed ID: 37860995
[TBL] [Abstract][Full Text] [Related]
56. Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Kahwati LC; Asher GN; Kadro ZO; Keen S; Ali R; Coker-Schwimmer E; Jonas DE
JAMA; 2022 Jan; 327(4):368-383. PubMed ID: 35076660
[TBL] [Abstract][Full Text] [Related]
57. Population screening for abdominal aortic aneurysm: evaluating the evidence against screening criteria.
Nair N; Sarfati D; Shaw C
N Z Med J; 2012 Feb; 125(1350):72-83. PubMed ID: 22382259
[TBL] [Abstract][Full Text] [Related]
58. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
[TBL] [Abstract][Full Text] [Related]
59. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
Shantsila E; Wolff A; Lip GY; Lane DA
Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
[TBL] [Abstract][Full Text] [Related]
60. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
Rhys GC; Azhar MF; Foster A
Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
